Intestinal fatty acid binding protein as a marker for intra-abdominal pressure-related complications in patients admitted to the intensive care unit; study protocol for a prospective cohort study (I-Fabulous study)

Table 1 Schedule of enrolment, interventions, and assessments

	Study period
	Enrolment*	Measurement **	Close-out
TIMEPOINT	<T ₀	T ₀ *to T* ₇₂	*ICU discharge*
ENROLMENT:
Eligibility screen	X
Informed Consent	X
ASSESSMENTS:
Baseline variables	X
Disease-related variables	X
IAP measurement		X
Blood sample		X
Urine sample		X
I-FABP measurement		X
Claudin-3 measurement		X
Creatinine measurement		X
Treatment-related variables		X
SOFA score		X
Adverse events		X	X
Length of ICU stay		X	X
Mortality during ICU stay		X	X
Secondary interventions		X	X

*Patients are considered eligible as soon as two IAH risk factors are present. This can either be at ICU admission or later on during ICU stay.
**Patients are followed until 72 hours or until discharge from the ICU, whichever comes first. Measurements are performed every six hours.

ISSN: 1757-7241